Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: EaglePutt who wrote (81694)	6/19/2002 4:28:51 PM
From: Softechie	Read Replies (1) \| Respond to of 99280

IMCL Imclone receives notice letter from SEC (11.41 +0.33) Announces it has received a written "Wells Notice" from the staff of the Securities and Exchange Commission (SEC), indicating that the staff is considering recommending the Commission bring an action against the Company; letter pertains to the company's disclosure immediately following its receipt of a Refusal-to-File letter from the FDA on December 28, 2001 for its biologics license application for ERBITUX.